GENEREX BIOTECHNOLOGY CORP (GNBT)

Recent Material Events for GENEREX BIOTECHNOLOGY CORP
Date Description
Dec 14, 2012 On December 13, 2012, Nola Masterson. tendered her resignation from the board of directors of Generex Biotechnology Corporation, effective on December 14, 2012.
Dec 11, 2012 On December 10, 2012, Generex Biotechnology Corporation (the “Company”) entered into a securities purchase agreement with certain investors, pursuant to which the Company agreed to sell an aggregate of 750 shares of its newly designated n
Dec 06, 2012 On November 30, 2012, two wholly owned subsidiaries of Generex Biotechnology Corporation received mortgage loans in the aggregate amount of CDN $855,000 [US $863,000] from Frontenac Mortgage Investment Corporation. The loans were secured by real esta
Oct 15, 2012 Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and &l
Jun 22, 2012 (e) On June 6, 2012, the Board of Directors approved the following stock option grants to certain of Company’s named executive officers and directors in full and final payment of the Company’s obligation to pay suc
Jun 20, 2012 On June 19, 2012, Generex Biotechnology Corporation (the “Company”) held its Annual Meeting at the Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, 160 College Street, Toronto, Ontario, Canada. The f
Feb 01, 2012 On January 31, 2012, Generex Biotechnology Corporation (the “Company”) entered into a securities purchase agreement with certain investors, pursuant to which the Company agreed to sell an aggregate of 2,000 shares of its newly designated
Feb 01, 2012 On January 31, 2012, Generex Biotechnology Corporation (the “Company”) entered into a securities purchase agreement with certain investors, pursuant to which the Company agreed to sell an aggregate of 2,000 shares of its newly designated
Jan 24, 2012 On January 19, 2012, two wholly owned subsidiaries of Generex Biotechnology Corporation (“Generex”) received mortgage loans in the aggregate amount of CDN $2,500,000 [US $2,475,000 ] from a private lender. The loans were secured by real e
Dec 23, 2011 During the period July 1 through November 30, 2011 Generex Biotechnology Corporation (the” Company”) issued, pursuant to a contractual commitment, 750,000 shares of common stock, in the aggregate, to a consultant for services rendered. Th